Founded in 2013, Oura Health operates in wearable health technology (smart ring). Investors last valued the company at $11B. Its shares do not trade on a public exchange.
2 valuations. The latest, $11B post-money, was set by the Series E in Oct 2025.
DexcomLEADMMSD CapitalLEADBBold Capital PartnersLEADTTesiLEADJJoi ItoLEADJJaan TallinnLEAD
Lifeline VenturesLEADFFidelity ManagementLEADTThe Chernin GroupLEADEElysian Park VenturesLEAD
TemasekLEADJJAZZ Venture PartnersLEADEEisaiLEADIICONIQAAtreidesWWhale RockEElysian ParkDexcomMSD CapitalBold Capital PartnersTesiOura Health makes the Oura Ring, a smart ring that tracks sleep, activity, stress and other biometric signals through a companion app, and the company is building toward a broader preventative-health platform. Founded in Oulu, Finland in 2013 by Petteri Lahtela, Kari Kivelä and Markku Koskela, Oura is now headquartered in San Francisco with other offices in Oulu, Helsinki and San Diego.
The company introduced its first ring via Kickstarter in 2016 and launched it publicly at the Slush conference in 2017. By September 2025 more than 5.5 million Oura Rings had been sold, and Oura employs more than 1,200 people across a science team that includes more than 50 PhDs.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Oura Health.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Oura Health availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Oura Health included.
Lead investors for each round are in the funding timeline.
The closest wearable health technology (smart ring) peers are on the competitors page.
Current status: filed.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
